Blue Light Phototherapy

Development & Preliminary Clinical Validation Blue Light Phototherapy Systems for T-Cell

This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.

Inclusion Criteria:

1. Patient's aged 18-89 at time of enrollment
2. Previous diagnosis of psoriasis vulgaris or Grover's disease

Exclusion Criteria:

1. All Groups: Subjects who are younger than 18 years of age or older than 90 years of age

2. Patients who have received topical or systemic treatment within the prior 2 weeks of planned phototherapy

3. Patients prescribed any of the following drugs for issues not related to their psoriasis or Grover's disease

   • topical steroids
   • calcineurin inhibitors
   • methotrexate
   • retinoids
   • biologic agents

4. Unable to schedule phototherapy sessions

5. We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations.